Çağdaş Yavaş

532 total citations
49 papers, 400 citations indexed

About

Çağdaş Yavaş is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Çağdaş Yavaş has authored 49 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 14 papers in Surgery. Recurrent topics in Çağdaş Yavaş's work include Endometrial and Cervical Cancer Treatments (10 papers), Effects of Radiation Exposure (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Çağdaş Yavaş is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Effects of Radiation Exposure (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Çağdaş Yavaş collaborates with scholars based in Türkiye. Çağdaş Yavaş's co-authors include Güler Yavaş, Deniz Yüce, Çetin Çeli̇k, Gökhan Özyiğit, Murat Araz, Mustafa Cengiz, M. Gürkaynak, Fadıl Akyol, Ferah Yıldız and Faruk Zorlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gynecologic Oncology and Journal of Thoracic Oncology.

In The Last Decade

Çağdaş Yavaş

45 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Çağdaş Yavaş Türkiye 12 130 104 97 68 58 49 400
Güler Yavaş Türkiye 13 139 1.1× 130 1.3× 116 1.2× 81 1.2× 62 1.1× 75 500
Cornelius Maihöfer Germany 5 66 0.5× 92 0.9× 54 0.6× 64 0.9× 37 0.6× 6 290
Luc Ollivier France 9 115 0.9× 109 1.0× 37 0.4× 45 0.7× 39 0.7× 33 376
Shung‐Shung Sun Taiwan 13 135 1.0× 110 1.1× 118 1.2× 183 2.7× 10 0.2× 62 539
Chia Hung Kao Taiwan 12 137 1.1× 105 1.0× 113 1.2× 159 2.3× 13 0.2× 28 483
Wainwright Jaggernauth United States 11 85 0.7× 66 0.6× 72 0.7× 58 0.9× 7 0.1× 24 333
Paulo Eduardo Novaes Brazil 14 247 1.9× 165 1.6× 124 1.3× 69 1.0× 88 1.5× 30 563
Kurt Meyer United States 10 275 2.1× 117 1.1× 55 0.6× 20 0.3× 204 3.5× 14 492
Joseph Song United States 13 117 0.9× 56 0.5× 77 0.8× 28 0.4× 26 0.4× 25 329
Ashok Muthukrishnan United States 9 141 1.1× 45 0.4× 65 0.7× 40 0.6× 13 0.2× 40 280

Countries citing papers authored by Çağdaş Yavaş

Since Specialization
Citations

This map shows the geographic impact of Çağdaş Yavaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Çağdaş Yavaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Çağdaş Yavaş more than expected).

Fields of papers citing papers by Çağdaş Yavaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Çağdaş Yavaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Çağdaş Yavaş. The network helps show where Çağdaş Yavaş may publish in the future.

Co-authorship network of co-authors of Çağdaş Yavaş

This figure shows the co-authorship network connecting the top 25 collaborators of Çağdaş Yavaş. A scholar is included among the top collaborators of Çağdaş Yavaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Çağdaş Yavaş. Çağdaş Yavaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Önal, Cem, et al.. (2023). The impact of margin reduction on radiation dose distribution of ultra‐hypofractionated prostate radiotherapy utilizing a 1.5‐T MR‐Linac. Journal of Applied Clinical Medical Physics. 25(1). e14179–e14179. 4 indexed citations
3.
Önal, Cem, Gürcan Erbay, Ozan Cem Güler, Çağdaş Yavaş, & Ezgi Oymak. (2023). Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients. The Prostate. 83(12). 1158–1166. 7 indexed citations
4.
Yavaş, Güler, et al.. (2022). Cardiac angiosarcoma treated with 1.5 Tesla MR-guided adaptive stereotactic body radiotherapy – Case report and review of the literature. International Journal of Surgery Case Reports. 98(C). 107521–107521. 6 indexed citations
5.
Önal, Cem, Ezgi Oymak, Ozan Cem Güler, et al.. (2022). Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study. Strahlentherapie und Onkologie. 199(5). 456–464. 3 indexed citations
6.
Çelik, Zeliha Esin, et al.. (2020). Spironolactone ameliorates the radiation-induced late fibrosis in salivary glands in a rat model. Iranian Journal of radiation research. 18(1). 149–155. 1 indexed citations
7.
Yavaş, Güler, et al.. (2019). The impact of spironolactone on the lung injury induced by concomitant trastuzumab and thoracic radiotherapy. Iranian Journal of radiation research. 17(1). 87–95. 8 indexed citations
8.
Akand, Murat, et al.. (2018). Aggressive treatment for urothelial cancer-complete urinary tract extirpation: Operative feasibility in two cases. SHILAP Revista de lepidopterología. 45(5). 393–397. 3 indexed citations
9.
Yavaş, Güler, et al.. (2018). P1.16-28 The Impact of Spironolactone on the Lung Injury Induced by Concomitant Trastuzumab and Thoracic Radiotherapy. Journal of Thoracic Oncology. 13(10). S638–S638. 3 indexed citations
10.
Yavaş, Güler, et al.. (2017). Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy. Reports of Practical Oncology & Radiotherapy. 22(4). 295–302. 10 indexed citations
11.
Yavaş, Güler, et al.. (2017). Locally advanced squamous cell cervical cancer in a patient with septate uterus. Journal of Contemporary Brachytherapy. 5(5). 487–489. 4 indexed citations
12.
Yavaş, Güler, Çağdaş Yavaş, Nasuh Utku Doğan, et al.. (2015). Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long term follow-up: A two-year prospective single center study. Gynecologic Oncology. 137. 192–193. 1 indexed citations
13.
Yavaş, Güler, et al.. (2014). Dosimetric comparison of two different whole brain radiotherapy techniques in patients with brain metastases: How to decrease lens dose?. Iranian Journal of radiation research. 12(4). 311–317. 2 indexed citations
14.
Yavaş, Güler, et al.. (2013). Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?. Medical Hypotheses. 81(2). 231–234. 5 indexed citations
15.
Yavaş, Güler, et al.. (2012). DOSIMETRIC COMPARISON OF WHOLE BREAST RADIOTHERAPY USING FIELD IN FIELD AND CONFORMAL RADIOTHERAPY TECHNIQUES IN EARLY STAGE BREAST CANCER. Iranian Journal of radiation research. 10(34). 131–138. 10 indexed citations
16.
Yavaş, Güler, et al.. (2012). Evaluation of the acute effect of palonosetron on transmural dispersion of myocardial repolarization.. PubMed. 16(4). 462–8. 16 indexed citations
17.
Yavaş, Güler, et al.. (2012). HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature. Breast Cancer. 22(4). 432–436. 9 indexed citations
18.
Yavaş, Güler, et al.. (2012). Prospective Assessment of Quality of Life and Psychological Distress in Patients With Gynecologic Malignancy. International Journal of Gynecological Cancer. 22(6). 1096–1101. 21 indexed citations
19.
Yavaş, Çağdaş, Faruk Zorlu, Gökhan Özyiğit, et al.. (2011). Prospective assessment of health-related quality of life in patients with low-grade glioma. Supportive Care in Cancer. 20(8). 1859–1868. 19 indexed citations
20.
Genç, Mine, et al.. (2008). Correliation Between Osteopontin Protein Expression and Histological Grade of Astrocytomas. Pathology & Oncology Research. 15(2). 203–207. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026